LogFrog DB does not have a website to sync data too and for some that might be an issue. It should not be. The application stands alone very nicely. Data backup to Google is secure and as reliable as any website.
LogFrog DB is fun to use. The data can be saved and viewed in manners no other app I have used can. Not having a website to sync your data and view it with ease is a small setback. Not everyone has a Google account, nor do they want one. I have several and my guess is most nerds do too. If e-mail exporting was done with an attachment alongside the embedded text, that would be better than my work around. Some people will say it lacks detailed food tracking ability, I say great. I have a food logging app that I love. I would rather have a diabetes app that tracks carbs only than one that does a half-!#% job of tracking all food data. At least one diabetes app I am currently testing does sync with another food app. But that the food app sucks! Where is the benefit to me?
LogFrog DB has set a new standard for ease of use and simplicity in design. It will be the bench mark by which I measure other diabetes management apps.
LogFrog DB on my iPhone has been a valuable tool for helping me manage my diabetes. Regular blood glucose testing is very important for any diabetic. Recording those readings and events that affect glucose levels can greatly improve your understanding of what steps you need to take to improve your health.
When entering data is inconvenient, cumbersome or boring, I have a hard time recording the information I know I should. This app is not inconvenient, not cumbersome and not boring.
LogFrog DB Website (opens new window)
The meta-analysis included data from eight observational cohort studies and 11 randomized controlled trials that involved diabetes and measuring vitamin D. The investigators, who were from Tufts Medical Center and Carney Hospital in Massachusetts, found that overall, individuals who consumed more than 500 International Units (IUs) per day of vitamin D had a 13 percent reduced risk of type 2 diabetes when compared with those who consumed less than 200 IU per day.
In type 2 diabetes, the body stops responding efficiently to insulin, a hormone that controls blood sugar. To compensate for the insensitivity to insulin, many diabetes drugs work by boosting insulin levels; for example, by injecting more insulin or by increasing the amount of insulin secreted from the pancreas. The new study, published in the June 9 issue of PLoS ONE, showed that a different approach could also be effective for treating diabetes — namely, blocking the breakdown of insulin, after it is secreted from the pancreas.